In addition, erlotinib-resistant NSCLC cell lines exhibit a mesenchymalphenotype (decreased E-cadherin expression and induction of vimentin andN-cadherin) and are characterized by the activation of not only TWIST1, butalso Snail, Slug, and ZEB1. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.